CXCL12 and acute myeloid leukemia: To test that notion, CXCR4 surface levels were measured in U937 (Fig 6A, 6B) or AML-193 (Fig 6C, 6D) cells treated with the receptor antagonists AMD3100 or BL-8040 and compared against cells incubated with CXCL12-LD.